Zdrowie i gospodarka · 12/09/2018

FDA Hosts Public Workshop to Discuss Biomarkers for Organ Transplant Patients

The FDA is hosting a public workshop to explore the use of biomarkers in determining immunologic risk for organ rejection or tolerance in transplant patients, with the goal of developing new treatments and improving patient outcomes.